Literature DB >> 15665109

Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene.

Donald Metcalf1, Marina R Carpinelli, Craig Hyland, Sandra Mifsud, Ladina Dirago, Nicos A Nicola, Douglas J Hilton, Warren S Alexander.   

Abstract

Mpl(-/-) mice bearing the Plt3 or Plt4 mutations in the c-Myb gene exhibit thrombopoietin (TPO)-independent supraphysiological platelet production accompanied by excessive megakaryocytopoiesis and defective erythroid and lymphoid cell production. To better define the cellular basis for the thrombocytosis in these mice, we analyzed the production and characteristics of megakaryocytes and their progenitors. Consistent with thrombocytosis arising from hyperactive production, the high platelet counts in mice carrying the c-Myb(Plt4) allele were not accompanied by any significant alteration in platelet half-life. Megakaryocytes in c-Myb mutant mice displayed reduced modal DNA ploidy and, among the excessive numbers of megakaryocyte progenitor cells, more mature precursors were particularly evident. Megakaryocyte progenitor cells carrying the Plt3 or Plt4 c-Myb mutations, but not granulocyte-macrophage progenitors, exhibited 200-fold enhanced responsiveness to granulocyte-macrophage colony-stimulating factor (GM-CSF), suggesting that altered responses to cytokines may contribute to expanded megakaryocytopoiesis. Mutant preprogenitor (blast colony-forming) cells appeared to have little capacity to form megakaryocyte progenitor cells. In contrast, the spleens of irradiated mice 12 days after transplantation with mutant bone marrow contained abundant megakaryocyte progenitor cells, suggesting that altered c-Myb activity skews differentiation commitment in spleen colony-forming units (CFU-S) in favor of excess megakaryocytopoiesis.

Entities:  

Mesh:

Year:  2005        PMID: 15665109     DOI: 10.1182/blood-2004-12-4806

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Regulation of hematopoietic stem cells by their mature progeny.

Authors:  Carolyn A de Graaf; Maria Kauppi; Tracey Baldwin; Craig D Hyland; Donald Metcalf; Tracy A Willson; Marina R Carpinelli; Gordon K Smyth; Warren S Alexander; Douglas J Hilton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

Review 2.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia.

Authors:  Douglas J Hilton; Benjamin T Kile; Warren S Alexander
Journal:  Blood       Date:  2009-02-27       Impact factor: 22.113

Review 4.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

5.  Effect of increased HoxB4 on human megakaryocytic development.

Authors:  Yiming Zhong; Brent Sullenbarger; Larry C Lasky
Journal:  Biochem Biophys Res Commun       Date:  2010-06-22       Impact factor: 3.575

6.  c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Authors:  Yuji Nakata; Susan Shetzline; Chizuko Sakashita; Anna Kalota; Ravikumar Rallapalli; Stephen I Rudnick; Yi Zhang; Stephen G Emerson; Alan M Gewirtz
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

7.  The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.

Authors:  Huiwu Zhao; Anna Kalota; Shenghao Jin; Alan M Gewirtz
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

8.  Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression.

Authors:  Charlene F Barroga; Hang Pham; Kenneth Kaushansky
Journal:  Exp Hematol       Date:  2008-09-23       Impact factor: 3.084

9.  C-myb Plays an Essential Role in the Protective Function of IGF-1 on Cytotoxicity Induced by Aβ25-35 via the PI3K/Akt Pathway.

Authors:  Jingyu Zhang; Yongwei Shu; Yang Qu; Lina Zhang; Tingting Chu; Yonghui Zheng; Hong Zhao
Journal:  J Mol Neurosci       Date:  2017-11-06       Impact factor: 3.444

10.  Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice.

Authors:  Maria Kauppi; James M Murphy; Carolyn A de Graaf; Craig D Hyland; Kylie T Greig; Donald Metcalf; Adrienne A Hilton; Nicos A Nicola; Benjamin T Kile; Douglas J Hilton; Warren S Alexander
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.